Bellerophon Therapeutics, Inc. BLPH

Set alert

Price alert · BLPH

All alert types
0.01 +0.01 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
146.79K
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.45
Beta
0.60
Short ratio
0.39
Inst. own
44.43%
Dividend
0.00
Ex-div date
Earnings
Dec 17, 2024
50-d avg
4.34
200-d avg
3.45
1y target
2.00

3M chart

Chart tools
Interval

Events in this range
  • Sep 30, 2024Earnings: —; estimate 0; surprise —%
  • Dec 17, 2024Earnings: —; estimate 0; surprise —%
Signals (6)
NameDateAgo
RSI: OversoldDec 18, 20241 year ago
SMA: BearishDec 9, 20241 year ago
RSI: OversoldDec 9, 20241 year ago
MACD: Sell SignalDec 3, 20241 year ago
RSI: OverboughtNov 5, 20241 year ago
SMA: BullishOct 11, 20242 years ago

Analyst view

Consensus: buy

Buy
Price target (mean) 2.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 4
  • 2 months ago 2
  • 3 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BLPH analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.40-0.42 – -0.39-0.43+7.0%00.0%2
Next quarter-0.42-0.44 – -0.41-0.53+20.8%00.0%2
Current year-1.05-1.11 – -1.00-2.08+49.5%5.64M0.0%2
Next year-1.67-1.82 – -1.53-1.05-59.0%1.33M-76.4%2

Upgrades and downgrades

The latest rating changes

BLPH analyst upgrades and downgrades
DateFirmActionFromTo
Jun 6, 2023HC Wainwright & Co.MaintainedBuyBuy
Jun 6, 2023Laidlaw & Co.DowngradeBuyHold
May 9, 2023Laidlaw & Co.Initiated—Buy
Apr 4, 2023HC Wainwright & Co.Reiterated—Buy
Nov 25, 2020JefferiesInitiated—Buy
Nov 25, 2020Maxim GroupInitiated—Buy
Nov 25, 2020H.C. WainwrightInitiated—Buy
Nov 25, 2020Leerink SwannInitiated—Outperform
Nov 25, 2020SunTrust Robinson HumphreyInitiated—Buy
Nov 25, 2020Cowen & Co.Initiated——